Stanford: Human Tissue Fills 90% of Mouse Brain Cortex
Stanford scientists transplanted human brain organoids into mice lacking a cortex; in three months the tissue grew nearly fivefold and filled over 90% of the cortex, a study in Nature shows.

A team of scientists at Stanford University, led by neuroscientist Sergiu Pasca, transplanted human brain organoids, tissue grown in the lab from stem cells, into mice genetically altered to lack most of their cortex and hippocampus. The study was published on September 16 in the journal Nature. Within three months, the human tissue had grown nearly fivefold and filled more than 90% of the space set aside for the cortex, producing a model for studying human neural circuits directly inside a living organism.
Organoids, small three dimensional structures resembling brain cortex, are made from skin or blood cells that are reprogrammed into stem cells and then guided to develop as brain tissue. The idea of growing such structures in a lab dish has been around since the start of the last decade, but until now they lacked a connection to a living nervous system and to sensory input. The same team transplanted human organoids into newborn rats back in 2022, and the human cells filled about a third of one side of the rat cortex. Progress was limited at the time because rat neurons mature faster than human ones, so the human tissue would outpace its own development before the host animal reached adulthood.
For the new experiment, the researchers turned to mice instead of rats, genetically altered to lack about 98% of the tissue that makes up the cortex and hippocampus, two structures that together account for roughly half the brain’s total volume. Even so, the authors say, these mice were surprisingly functional. The space left by the missing tissue was then filled with human organoids grown from healthy donor stem cells. The transplant succeeded in 25 of 29 attempts, carried out shortly after the animals were born.
Over the following three months, the human tissue developed into several types of cortical cells, including so called von Economo neurons, which have been linked to dementia and which scientists had not previously managed to grow in a lab dish. Although the human tissue still lacked the distinctive layering of a mature cortex, it did connect with the mouse’s nervous system and form functional links with the host’s brain and spinal cord.
“These animals retain the mouse nervous system, but they contain a larger volume of human cortical tissue that develops, integrates and forms connections within it,” Sergiu Pasca, a Stanford University neuroscientist and the study’s lead author, told Reuters, as reported by Yahoo News.
The researchers then used the model to mimic cerebral palsy, a disorder caused by damage to the developing brain. The transplanted animals were exposed to a temporary lack of oxygen, after which the human tissue showed signs of cellular damage and the mice developed gait and movement coordination problems similar to those the disease causes in humans. Ordinary lab mice without human tissue showed none of these effects.
“In the xenocortical mice, the period of low oxygen caused significant damage to the human cortical cells, accompanied by gait and motor coordination problems,” Pasca said in the same comments to Reuters.
The authors say the model could speed up research into autism, epilepsy, cerebral palsy and schizophrenia, and Pasca told Science News that the team’s goal is to make the developmental and functional aspects of the human brain available for study, so that therapies can be developed more easily.
“Our goal was to make aspects of human brain development and function available for study, so we could develop therapies,” Sergiu Pasca told Science News.
What the Study Does Not Show
The scale of humanization in the mouse brain has also raised ethical questions, so before publishing the paper Pasca brought in an outside panel of experts, chaired by bioethicist Insoo Hyun of the Yong Loo Lin School of Medicine at the National University of Singapore. Neurosurgeon H. Isaac Chen of the University of Pennsylvania, who was not involved in the research, called the approach bold and said the extent of tissue humanization raises questions about the ethical limits of such experiments, while noting that Pasca had made an unusual effort to address those questions openly.
The study is a proof of concept experiment on a small number of animals, 25 successfully transplanted mice, and it does not show that the transplanted human tissue gives mice any extra cognitive ability. On tests of fine motor skills and memory, the transplanted mice performed somewhere between mice with an intact cortex and those lacking a cortex entirely, meaning within the expected range rather than above it. The paper also does not show that the model is ready for testing specific therapies in humans, or what happens to the human tissue over a longer period than the three months of observation covered here. It is a model for studying brain development and disease, not a substitute for clinical trials in humans.


